| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-06 |